Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRADIMED CORP Director's Dealing 2020

Jul 28, 2020

32324_dirs_2020-07-27_4d858ad2-f071-4141-98d1-603fdbfdf474.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2020-07-24

Reporting Person: Waldman Louis S. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-07-24 Common Stock M 5155 Acquired 40155 Direct
2020-07-24 Common Stock F 1254 $23.47 Disposed 38901 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-07-24 Restricted Stock Units $ M 750 Disposed Common Stock (750) Direct
2020-07-24 Restricted Stock Units $ M 1476 Disposed Common Stock (1476) Direct
2020-07-24 Restricted Stock Units $ M 1181 Disposed Common Stock (1181) Direct
2020-07-24 Restricted Stock Units $ M 1748 Disposed Common Stock (1748) Direct

Footnotes

F1: As previously disclosed, the reporting person received restricted stock units under the Issuer's 2014 Equity Incentive Plan on December 14, 2016, December 4, 2017, December 7, 2018, and December 7, 2019. Pursuant to the reporting person's separation agreement with the Issuer (the "Separation Agreement"), upon his separation from the Issuer on July 24, 2020 (the "Retirement Date"), all of his unvested restricted stock units, amounting to 5,155 shares of common stock, accelerated and vested as of the Retirement Date as follows: (i) 750 unvested restricted stock units accelerated and vested from the December 14, 2016 grant; (ii) 1,476 unvested restricted stock units accelerated and vested from the December 4, 2017 grant; (iii) 1,181 unvested restricted stock units accelerated and vested from the December 7, 2018 grant; and (iv) 1,748 unvested restricted stock units accelerated and vested from the December 7, 2019 grant (collectively, the "RSUs").

F2: Shares surrendered to the Issuer for payment of tax liability incident to the accelerated vesting of a total of 5,155 restricted stock units.

F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4: All of the unvested RSUs were accelerated on the Retirement Date pursuant to the terms of the Separation Agreement.